Healthcare professionals should be aware of the potential risk of pulmonary aspiration in patients using GLP-1 or dual GIP/GLP-1 receptor agonists who undergo surgery or procedures with general anaesthesia or deep sedation.
This content is sourced from MHRA and reproduced for clinical reference. ClinicalIQ does not alter source content.